VisionGate Competitors and Similar CompaniesClear all

VisionGate's competitors and similar companies include Adaptix, ANT Neuro, Talis Biomedical and Decision Sciences Medical.

	VisionGate VisionGate is a biotechnology company that develops 3D cell imaging platforms.	Adaptix Adaptix provides technology to allow low-cost low-dose 3D imaging at the bedside or GP's clinic.	ANT Neuro ANT Neuro is a company that provides solutions for neuroscience and neurodiagnostics.	Talis Biomedical Talis Biomedical is a company specializing in biomedical diagnostics.	Decision Sciences Medical Decision Sciences Medical is a company developing medical imaging solutions.
Founding Date	Founding Date 2001	Founding Date N/A	Founding Date 1996	Founding Date 2010	Founding Date 2012
Type	Type Private	Type Private	Type Subsidiary	Type Public	Type Private
Tags	Tags Healthcare biotech medical diagnostics medical imaging medtech platform	Tags Healthcare medical diagnostics medical imaging medtech	Tags Healthcare medical diagnostics medical imaging medtech	Tags Healthcare medical diagnostics medical imaging medtech	Tags Healthcare biotech medical devices medical diagnostics medical imaging medtech
Locations	Locations Phoenix, US HQ Woodinville, US	Locations Oxfordshire, GB HQ Chapelhall, GB Didcot, GB	Locations Hengelo, NL HQ Melbourne, AU Berlin, DE Hong Kong, HK Stevenage, GB Philadelphia, US	Locations Menlo Park, US HQ Chicago, US Chicago, US	Locations Poway, US HQ
Employees	Employees 24	Employees 751% decrease	Employees 691% decrease	Employees 993% decrease	Employees 15
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) £125k (FY, 2018)	Revenue (est.) N/A	Revenue (est.) $2.1m (FY, 2023)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods £463.2k (FY, 2018)	Cost of goods N/A	Cost of goods $41k (FY, 2023)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit (£338.2k) (FY, 2018)	Gross profit N/A	Gross profit $2.1m (FY, 2023)	Gross profit N/A
Net income	Net income N/A	Net income (£2.1m) (FY, 2018)	Net income N/A	Net income ($62m) (FY, 2023)	Net income N/A
Funding
Latest funding round	Latest funding round $ 36.6m (over 6 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 1.1m (over 12 years ago)
Total funding raised	Total funding raised $ 58.2m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 4.4m